CQO & The Triple Aim: Supply Chain's Strategic Connection Report

By AHRMM

As the Institute for Healthcare Improvement’s (IHI) Triple Aim continues to be adopted by hospitals and health systems as a framework for implementing major improvements, AHRMM has established a clear and important connection between AHRMM’s Cost, Quality, and Outcomes (CQO) Movement and the goals of the Triple Aim.

This approach, calling for improvement of the patient experience, the health of populations, and the reduction of per capita healthcare cost needs to be implemented by all healthcare stakeholders, with supply chain professionals as co-owners within this delivery-of-care model.

The report outlines the strategic role supply chain plays within each of the IHI’s five suggested components of a system that fulfills the Triple Aim. Read the report to gain an understanding of how you can:

  • support the use of data and analytics
  • establish collaborations across departments and communities
  • promote prevention and implement standardization and cost control metrics that are all needed to improve patient safety, patient outcomes, and patient satisfaction
  • and eliminate product waste and drive holistic, clinically integrated, and strategic care within the value-based reimbursement model

 

Related Resources

Case Studies
AHRMM is building a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and…
White Papers
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Dat
Webcast
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic
Webcast
In this short webcast, Tom Redding, managing director of healthcare services at St.
Webcast
This short webcast will give you a brief overview of the current ISM® Report On Business, share details surrounding the development of the new
Webcast
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the val